Bioventus BVS
NASDAQ BVS
$13.64 -0.19 (-1.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bioventus (BVS) Operating Margin Growth (3y) (2023 - 2026)

Analysis

Bioventus (BVS) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -201.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 722.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 162.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 586.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 887.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1,075.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 963.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 244.00
10 Bioventus 923.70 Mn 894.24 Mn 105.67 Mn 756.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 756.00
Mar 28, 2026 8,369.00
Dec 31, 2025 2,477.00
Sep 27, 2025 10,670.00
Jun 28, 2025 1,480.00
Mar 29, 2025 2,222.00
Dec 31, 2024 743.00
Sep 28, 2024 359.00
Jun 29, 2024 -1,559.00
Mar 30, 2024 -2,309.00
Dec 31, 2023 -513.00
Sep 30, 2023 -607.00
Jul 1, 2023 1,284.00
Apr 1, 2023 -9,384.00